evitria offers recombinant antibody production service for industrial applications as well as for research. Here you can find all articles about evitria’s services and the benefits for companies cooperating with evitria.
This post will highlight the core activities in the growing market of CROs, how to avoid the potential pitfalls of unreliable CROs, and point out how your organization can benefit from outsourcing to recombinant antibody expression service providers like evitria.
As is the case with a growing number of industries, the medical and pharmaceutical fields are increasingly turning to working with third-party providers. Manufacturers of antibody therapeutics are outsourcing certain process steps to contract manufacturers for various reasons, be it to cut costs or to speed up production.
Antibody development and antibody expression have become essential in life-science and the biopharmaceutical industry. In particular, advanced methods of creating and selecting recombinant antibodies have enabled science and medicine alike to progress in unanticipated speed.
From the application in medicine and science to recombinant antibody production and the advantages of recombinant Abs in contrast to traditional monoclonal antibodies, this article will teach you all you need to know about recombinant antibodies.
Generally speaking, antibodies of any kind, including recombinant and afucosylated antibodies, are Y-shaped proteins produced by the human body. As they are able to identify and neutralize foreign objects – in other words viruses – they play a major contributing role in keeping our body and immune system healthy.
Antibody-dependent cellular cytotoxicity is a key process of the immune system’s arsenal to ward off cancerous cells and infections. We show you important definitions and the ADCC mechanism and key facts on ADCC antibodies in this post.